Every article in our archive tagged Vulnerability Management.
Looking for a quick answer instead? The FDA medical device cybersecurity FAQ covers Section 524B scope, SBOMs, threat models, CR515 and GMLP, deficiencies, and postmarket duties.
Showing 5 of 5 articles tagged Vulnerability Management
FDA MDDT for cybersecurity: what the qualified MITRE CVSS rubric is, how medical device makers use it to score vulnerabilities, and where its limits are.
Read article
When to patch a medical device vulnerability: how controlled and uncontrolled risk, vendor CVE patches, and FDA reporting rules shape your remediation timeline.
Read article
Vulnerability management metrics for medical device makers: which KPIs to track, how to set targets by risk, and how they support FDA 524B postmarket plans.
Read article
VEX resources for medical device teams: a document guide, SBOM comparison, and common assessment mistakes, with evidence-based status and regulatory context.
Read article
The CISA KEV catalog explained: who must act on it, how it drives SBOM and VEX triage, and how it fits postmarket obligations under the FDA's guidance.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've supported 275+ FDA submissions, with zero cybersecurity rejections.
